West to evaluate Crystal Zenith technologies with Amgen
Plastic container avoids problems associated with glass
West Pharmaceutical Services, a global manufacturer of components and systems for injectable drug delivery, is to collaborate with Amgen to evaluate Daikyo Crystal Zenith technologies for drug containment.
No financial details about the agreement have been released.
West’s partner, Daikyo Seiko, is the developer of Crystal Zenith technologies, which are based on a polymeric container, using elastomeric components with Flurotec barrier film, and provided in a sterile, validated, ready-to-fill format. This avoids the problems associated with using glass vials.
West‘s chairman and ceo Donald Morel said: ‘Biopharmaceutical therapeutic products require a drug container that enables safe, effective and reliable containment.
‘We are delighted to formalise our plan to work with Amgen for evaluating the use of Daikyo Crystal Zenith in commercialising Amgen's therapeutics.’
Martin Van Trieste, senior vice president of quality at Amgen, said: ‘Amgen has had a long relationship with West and is excited about strengthening this relationship. We have been impressed with the innovations of West and Daikyo in container-closure systems.’